WO2006060202A3 - Imidazole derivatives for the treatment of psychiatric disorders - Google Patents

Imidazole derivatives for the treatment of psychiatric disorders Download PDF

Info

Publication number
WO2006060202A3
WO2006060202A3 PCT/US2005/042007 US2005042007W WO2006060202A3 WO 2006060202 A3 WO2006060202 A3 WO 2006060202A3 US 2005042007 W US2005042007 W US 2005042007W WO 2006060202 A3 WO2006060202 A3 WO 2006060202A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
psychiatric disorders
imidazole derivatives
imidazole
derivatives
Prior art date
Application number
PCT/US2005/042007
Other languages
French (fr)
Other versions
WO2006060202A2 (en
Inventor
Astrid Ortiz
Original Assignee
Bayer Pharmaceuticals Corp
Astrid Ortiz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp, Astrid Ortiz filed Critical Bayer Pharmaceuticals Corp
Publication of WO2006060202A2 publication Critical patent/WO2006060202A2/en
Publication of WO2006060202A3 publication Critical patent/WO2006060202A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

This invention relates to imidazole derivatives which are useful in treating psychiatric disorders.
PCT/US2005/042007 2004-11-30 2005-11-18 Imidazole derivatives for the treatment of psychiatric disorders WO2006060202A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63202804P 2004-11-30 2004-11-30
US60/632,028 2004-11-30

Publications (2)

Publication Number Publication Date
WO2006060202A2 WO2006060202A2 (en) 2006-06-08
WO2006060202A3 true WO2006060202A3 (en) 2006-12-14

Family

ID=36565537

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/042007 WO2006060202A2 (en) 2004-11-30 2005-11-18 Imidazole derivatives for the treatment of psychiatric disorders

Country Status (1)

Country Link
WO (1) WO2006060202A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235854A1 (en) * 2001-09-21 2004-11-25 Kruse Cornelis G. 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
US20040248956A1 (en) * 2002-01-29 2004-12-09 Hagmann William K Substituted imidazoles as cannabinoid receptor modulators

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040235854A1 (en) * 2001-09-21 2004-11-25 Kruse Cornelis G. 1H-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1 antagonistic activity
US20040248956A1 (en) * 2002-01-29 2004-12-09 Hagmann William K Substituted imidazoles as cannabinoid receptor modulators

Also Published As

Publication number Publication date
WO2006060202A2 (en) 2006-06-08

Similar Documents

Publication Publication Date Title
NL301145I1 (en)
AP2379A (en) Imidazole compounds for the treatment of neurodegenerative disorders.
HRP20130797T1 (en) Condensed imidazolo derivatives for the inhibition of aldosterone synthase and aromatase
ZA200802163B (en) 5-(phenylisoxazolylethoxy)-triazol-3-YL substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders
ZA200700384B (en) Hydantoin derivatives for the treatment of inflammatory disorders
IL187168A0 (en) Improved nanobodiestm for the treatment of aggregation-mediated disorders
WO2005079756A3 (en) Combination of a nmda receptor antagonist and an anti-depressive drug mao-inhibitor or a gadph-inhibitor for the treatment of psychiatric conditions
WO2008128072A3 (en) Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
WO2006017384A3 (en) Indazoles useful in treating cardiovascular diseases
WO2007047447A3 (en) Diuretic-like compound analogs useful for regulation of central nervous system disorders
BRPI0820440A2 (en) Aldh-2 inhibitors in the treatment of psychiatric disorders.
WO2005086656A3 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
IL186748A0 (en) 4 - phenyl - 5 - oxo 1, 4, 5, 6, 7, 8 - hexahydroquinoline derivatives for the treatment of infertility
WO2006018188A3 (en) Substituted hydantoins
SI1900362T1 (en) Alfa-aminoamide derivatives useful in the treatment of addictive disorders
ZA200805159B (en) Imidazole derivatives for the treatment of gastrointestinal disorders
WO2007030438A3 (en) Aminopurine derivatives for treating neurodegenerative diseases
IL189524A0 (en) Imidazole compounds for the treatment of neurological disorders
EP1814535A4 (en) Nitrosated and nitrosylated compounds, compositions and methods for the treatment of ophthalmic disorders
MX2007009108A (en) Imidazole derivatives.
WO2008050133A3 (en) Inhibition of beta-amyloid aggregation
WO2005112923A3 (en) 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
WO2006060202A3 (en) Imidazole derivatives for the treatment of psychiatric disorders
WO2006060201A3 (en) Pyrazole derivatives for the treatment of psychiatric disorders
WO2006060203A3 (en) Imidazole derivatives for the treatment of dementia and related disorders

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05849389

Country of ref document: EP

Kind code of ref document: A2